Skip to content

IlluminOss Hand Fracture International Clinical Feasibility Study

IlluminOss Medical- Photodynamic Bone Stabilization System- International Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00823251
Enrollment
4
Registered
2009-01-15
Start date
2008-12-31
Completion date
2013-02-28
Last updated
2017-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic Fractures

Brief summary

The purpose of this study is to assess the initial safety and technical feasibility of the IlluminOss System in the treatment of fractures of bones in the hand.

Interventions

The IlluminOss™ Bone Stabilization System is designed to deliver the device to the fracture site via the medullary canal of the bone using percutaneous techniques. Once the device is in place and has spanned the fracture site, the device is expanded and hardened to reduce and stabilize the fracture, to aid in the support and healing of the bone fracture by primary callous formation and remodeling.

Sponsors

IlluminOss Medical, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Skeletally mature * Patient or his/her legal guardian understands the nature of the procedure and is willing to comply with associated follow-up evaluations, and provides written informed consent prior to the procedure * Female patients must be of non-child bearing potential, or have a negative pregnancy test within prior 48 hours * Acute fracture of metacarpal or phalangeal bone(s) that requires reduction and internal fixation * Fracture has occurred within past 3 weeks * Fracture types: transverse, short oblique, or any fracture pattern in which the comminuted segment is equal to or less than the diameter of the bone at fracture site

Exclusion criteria

* Patient is pregnant, lactating or female patients who intend to become pregnant during the course of the study * Patient has experienced a crush, mangling, or burn type injury * Patient has probable history of infection or confirmed infection at baseline * Patient has previous diagnosis of a significant bone disorder that may impair bone healing * Patient has a life expectancy of \< 26 weeks * Pathological fracture secondary to tumor * Open fracture of Gustilo-Anderson Type II or III

Design outcomes

Primary

MeasureTime frame
Technical Success: Successful implantation of an IlluminOss bone-pin via percutaneous techniques at the target fracture location.Immediately post-surgery

Secondary

MeasureTime frame
Rate of Anatomic Alignment180 Day
Functionality Score180 Day
Grip Strength180 Day
Rate of Fracture Union180 day
Incidence of Reintervention of Target Fracture180 Day
Bone Pin Migration180 Day
Adverse Event Rate180 day
Range of Motion180 day

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026